Author

A. T. Raman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ChIP-seq· 3 Organism:human· 3 Research Focus:chromatin & epigenetic regulation· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

J. Schulz· 3 shared K. Rai· 3 shared M. Tang· 3 shared A. K. Ghosh· 2 shared C. Terranova· 2 shared E. Orouji· 2 shared M. Maitituoheti· 2 shared S. C. Callahan· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

J. Schulz

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

High Enhancer Activity is an Epigenetic Feature of HPV Negative Atypical Head and Neck Squamous Cell Carcinoma

S. C. Callahan, V. Kochat, Z. Liu, A. T. Raman, J. Schulz, C. Terranova, M. Divenko, A. Ghosh, M. Tang, C. Pickering, J. N. Myers, K. Rai

The paper identifies high enhancer activity in HPV-negative atypical HNSCC as linked to BET inhibitor resistance and upregulated signaling pathways.

bioRxiv · Sep 21, 2021Cancer Biology

H3K4me1-marked Enhancer Activation in Resistant Prostate Cancers Implicates SOX4 and MENIN Inhibition as Therapeutic Strategies

C. Terranova, M. Maitituoheti, A. T. Raman, M. Tang, N. E. Anvar, A. K. Ghosh, S. B. Amin, J. Schulz, E. Orouji, F. Giancotti, P. Troncoso, C. J. Logothetis, T. Thompson, K. Rai

The paper identifies H3K4me1-marked enhancers in therapy-resistant prostate cancers and suggests SOX4 and MENIN inhibition as therapeutic strategies.

bioRxiv · Sep 2, 2021 · PreprintCancer Biology

Chromatin State Dynamics Confers Specific Therapeutic Strategies in Enhancer Subtypes of Colorectal Cancer

E. Orouji, A. T. Raman, A. K. Singh, A. Sorokin, E. Arslan, A. K. Ghosh, J. Schulz, C. J. Terranova, M. Tang, M. Maitituoheti, S. C. Callahan, K. J. Tomczak, Z. Jiang, J. S. Davis, S. Ghosh, , K. Rai

This study identifies enhancer subtypes in colorectal cancer through epigenomic analysis and proposes targeted therapeutic strategies based on these subtypes.

bioRxiv · Sep 4, 2020Cancer Biology